Ethical Treatment of Animals
Our company is dedicated to the ethical and responsible treatment of all animals used in the development of medicines and vaccines. Decisions regarding animal care, use and welfare are made by balancing scientific knowledge and regulatory requirements with consideration of ethical and societal values.
MSD Animal Health firmly supports the responsible use of antibiotics to improve and maintain the health of animals. Antibiotics are life-saving veterinary products that treat bacterial infections in companion and food-producing animals. Their use in veterinary medicine also benefits humans by reducing the spread of disease between animals and humans; and helping facilitate a safe, efficient and sustainable food supply.
One Health refers to a collaborative, multisectoral, and multi-disciplinary approach that recognizes the interconnection between people, animals and environment—with the goal of achieving optimal health outcomes.
Our company fully supports taking a One Health approach to collaboratively improve health for the people and animals that share our complex and ever-changing environment. We are uniquely positioned, with our human and animal health businesses both rooted in strong science, to help lead and guide discussions about One Health issues.
Plasma-based products are used for both human and animal health and provide therapeutic benefits for a range of conditions. The safety and well-being of all animals is our first priority at MSD Animal Health. We only select partners that share these same values, and they are required to operate by the MSD Code of Conduct.
Facts about Bravecto
Nothing is more important to MSD Animal Health than the safety and efficacy of our products and the health and well-being of animals, which is why it is so important that we share the facts about Bravecto® (fluralaner).
Read the facts here
As new and evolving diseases and pathogens continue to endanger animal populations, MSD Animal Health, a leader in vaccine development, is at the forefront of bringing to market vaccine technology for optimal health of companion and food-producing animals through its SEQUIVITY™ Technology. The technology represents a revolutionary, flexible, rapid and targeted approach to the development of vaccines, using unique RNA Particles (RP), which are able to target a wide range of viruses and bacteria (pathogens).